South Korean biotech bets on donated human fat product to fix ‘Ozempic face’L&C Bio plans to launch an injectable skin booster made from donated human fat to treat weight-loss drug effects2-MIN READ2-MIN1Published: 12:25pm, 6 Aug 2026“Ozempic face” could spawn the next K-beauty craze. South Korean biotech L&C Bio plans to launch an injectable skin booster made from donated human fat to restore lost facial volume, betting demand for cosmetic fixes tied to blockbuster weight-loss drugs will drive its next phase of growth.L&C – which pioneered the use of donated human tissue in K-beauty skin boosters – developed the technology about five years ago, CEO Lee Whan Chul said in an interview. The company holds patents on the technology in South Korea, the US and China.South Korea has repeatedly turned niche cosmetic procedures into global beauty trends, from glass skin regimens to salmon sperm facials and L&C’s flagship human tissue treatment Re2O. The next wave may shift from improving skin quality to restoring facial and body volume, which L&C Bio’s new product is designed to support.Select VoiceSelect Speed0.8x0.9x1.0x1.1x1.2x1.5x1.75x00:0000:001.00x
SRCSouth China Morning Post
LANGEN
LEANCenter-Right
WORDS177
ENT8
THU · 2026-08-06 · 04:25 GMTBRIEF NSR-2026-0806-99614
NSR-2026-0806-99614News Report·EN·Technology
South Korean biotech bets on donated human fat product to fix ‘Ozempic face’
South Korean biotech company L&C Bio is set to launch an injectable skin booster made from donated human fat. This product aims to address "Ozempic face," a cosmetic concern arising from facial volume loss associated with weight-loss drugs like Ozempic.
BloombergSouth China Morning PostFiled 2026-08-06 · 04:25 GMTLean · Center-RightRead · 1 min
South China Morning PostFIG 01
Reading time
1min
Word count
177words
Sources cited
1cited
Entities identified
8entities
Quality score
100%
§ 01
Briefing Summary
AI-generatedNEWSAR · AI
South Korean biotech company L&C Bio is set to launch an injectable skin booster made from donated human fat. This product aims to address "Ozempic face," a cosmetic concern arising from facial volume loss associated with weight-loss drugs like Ozempic. L&C Bio, which has prior experience with human tissue in K-beauty products, developed this technology approximately five years ago and holds patents in South Korea, the US, and China. The company anticipates that the demand for cosmetic solutions for weight-loss drug side effects will fuel its growth. This move aligns with South Korea's history of popularizing niche cosmetic procedures globally, potentially shifting the focus from skin quality to restoring facial and body volume.
Confidence 0.90Sources 1Claims 5Entities 8
§ 02
Article analysis
Model · rule-basedFraming
Technology
Human Interest
Tone
Mixed Tone
AI-assessed
CalmNeutralAlarmist
Factuality
0.70 / 1.00
Factual
LowHigh
Sources cited
1
Limited
FewMany
§ 03
Key claims
5 extracted01
The company holds patents on the technology in South Korea, the US and China.
factualL&C Bio
Confidence
0.90
02
South Korean biotech L&C Bio plans to launch an injectable skin booster made from donated human fat to treat 'Ozempic face'.
factualL&C Bio
Confidence
0.90
03
L&C Bio developed the technology about five years ago.
factualCEO Lee Whan Chul
Confidence
0.90
04
South Korea has a history of turning niche cosmetic procedures into global beauty trends.
factualarticle
Confidence
0.80
05
The next wave of K-beauty may shift from improving skin quality to restoring facial and body volume.
predictionarticle
Confidence
0.70
§ 04
Full report
1 min read · 177 words§ 05
Entities
8 identifiedKey playerOppositionContextPositiveNeutralNegative
People1
Organizations1
§ 06
Keywords & salience
9 termsozempic face
1.00
l&c bio
0.90
injectable skin booster
0.80
donated human fat
0.80
weight-loss drugs
0.70
k-beauty
0.60
facial volume
0.50
cosmetic fixes
0.40
biotech
0.40
§ 07
Topic connections
Interactive graph No topic relationship data available yet. This graph will appear once topic relationships have been computed.